Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Minerva Neurosciences (NERV) Equity Average (2016 - 2026)

Minerva Neurosciences filings provide 2 years of Equity Average readings, the most recent being $18.0 million for Q4 2021.

  • On a quarterly basis, Equity Average fell 67.43% to $18.0 million in Q4 2021 year-over-year; TTM through Dec 2021 was $18.0 million, a 67.43% decrease, with the full-year FY2021 number at $30.3 million, down 24.62% from a year prior.
  • Equity Average hit $18.0 million in Q4 2021 for Minerva Neurosciences, down from $32.1 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $57.5 million in Q3 2020 to a low of $18.0 million in Q4 2021.